Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Next/Generation Psychedelics
Recent news which mentions Next/Generation Psychedelics
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
March 27, 2024
Tickers
ENVB
Tags
ENVB
Cannabis
Market News
From
Benzinga
Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder
March 15, 2024
Tickers
NEWS
Tags
News
Management
Legal
From
Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
December 03, 2023
Tickers
CYBN
Tags
Management
CYBN
News
From
Benzinga
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice
November 21, 2023
Tickers
CMND
Tags
Legal
Nasdaq Minimum Bid Price Rule
News
From
Benzinga
Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials
November 14, 2023
Tickers
ENVB
Tags
Markets
ENVB
News
From
Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
November 14, 2023
Tickers
ATAI
CMPS
Tags
Psychedelics
ATAI
Next/Generation Psychedelics
From
Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
Tags
FDA
Benzinga
Reunion Neuroscience Inc/
From
Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
September 06, 2023
Tickers
CMND
Tags
CMND
Psychedelics
Next/Generation Psychedelics
From
Benzinga
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
August 31, 2023
Tickers
CYBN
DMTTF
MSSTF
NUGL
Tags
DMTTF
Markets
CYBN
From
Benzinga
Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment
August 28, 2023
Tickers
ENVB
Tags
Next/Generation Psychedelics
Psychedelics
Penny Stocks
From
Benzinga
Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
August 16, 2023
Tickers
CYBN
Tags
CYBN
Management
Legal
From
Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
August 14, 2023
Tickers
ENVB
Tags
Psychedelics
Next/Generation Psychedelics
Benzinga
From
Benzinga
Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
August 08, 2023
Tickers
DRUG
Tags
News
clinical trials
Markets
From
Benzinga
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
August 01, 2023
Tickers
REUN
Tags
Next/Generation Psychedelics
private development
Psychedelics
From
Benzinga
Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application
July 18, 2023
Tickers
MSSTF
REUN
Tags
Rumors
Terran Biosciences
Psychedelics
From
Benzinga
Reunion Neuroscience On The Brink Of Going Private With Final Court Approval
July 17, 2023
Tickers
FTHWF
MSSTF
REUN
Tags
Management
REUN
MSSTF
From
Benzinga
Pioneering Psychedelics Scientist Alexander "Sasha" Shulgin's Legacy Lives On Via New Compounds And Research
July 10, 2023
Tags
Benzinga
Psychedelic/Assisted Therapies
the Alexander Shulgin Research Institute Inc/
From
Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
June 28, 2023
Tickers
LOBEF
Tags
Psychedelic/Assisted Therapies
Penny Stocks
Benzinga
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
News
BETRF
Guidance
From
Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
June 28, 2023
Tickers
CYBN
Tags
Markets
Guidance
Management
From
Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
June 27, 2023
Tickers
MSSTF
Tags
MSSTF
News
Legal
From
Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
June 13, 2023
Tickers
PMBHF
Tags
Management
PMBHF
News
From
Benzinga
Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update
May 30, 2023
Tickers
MYCOF
Tags
Next/Generation Psychedelics
Management
Psychedelics
From
Benzinga
This Company's Psilocybin-Based Non Hallucinogenic Compound Heads Toward Clinical Studies
May 28, 2023
Tags
psilocybin therapies
Psychedelic/Assisted Therapies
Benzinga
From
Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
May 10, 2023
Tickers
HUGE
Tags
Psychedelic/Assisted Therapies
Penny Stocks
Benzinga
From
Benzinga
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
May 09, 2023
Tags
Next/Generation Psychedelics
Psychoplastogens
Psychedelics
From
Benzinga
NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
May 05, 2023
Tags
Market News
Cannabis
Markets
From
Benzinga
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
April 26, 2023
Tickers
MSSTF
Tags
MSSTF
News
intellectual property
From
Benzinga
Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds
April 20, 2023
Tickers
DRUG
SILO
Tags
Guidance
Markets
stress levels
From
Benzinga
Are Next-Gen Psychedelics The Incoming Solution For Mental Health? Learn It All At Benzinga's Psychedelics Capital Conference
April 06, 2023
Tags
News
General
Markets
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.